We build an evidence-led integrative-support system alongside the standard of care — R&D in Amazonia, an operations hub in New York, and a clinic network. Evidence over promises.
Informational materials — not an offer or solicitation of securities, not investment advice, not a guarantee of returns, and not a medical claim. Integrative support is used together with the standard of care, never instead of it.
Patients receive the standard of care, but support, tolerability and quality of life remain underserved. We build that layer — disciplined, evidence-led, alongside treatment.
Integrative support around oncology is inconsistent, unmeasured and often overclaimed.
Demand for evidence-led integrative oncology and cross-border care is rising, and 2026 reference standards make alignment testable.
We size the market bottom-up; the model and figures are shared in the data room.
Ethnobotany translated into reproducible support protocols, aligned to 2026 standards.
Amazonian sourcing under ABS/Nagoya & SisGen, plus proprietary protocols and know-how.
Amazonia · New York · Kyiv · Barbados (priority) · Almaty.
Aggregate, de-identified data; complementary, never a replacement for treatment.
Pre-revenue. Highlights are qualitative; financials, market model and evidence are substantiated with sources in the data room. They are not financial results, projections or efficacy claims.
Support system (Ulgen · Ancestors · Red Laser), a clinic network on one standard, a privacy-respecting digital funnel, and an Amazonian R&D loop.
A scientific and clinical advisory function and an honesty standard govern every claim. Advisor profiles are available on request.
Qualified and accredited investors can request the deck, model, cap table and evidence dossier. Access is granted under NDA after a short review.
Prefer to reach us directly? Use the contact page →